Mesoblast Ltd (ASX:MSB) Stock News, Headlines & Updates
Mesoblast Ltd Stock News from GuruFocus
- 1
Jul 01, 2025
Mesoblast (MESO) Gains After FDA Supports BLA Application Plans
GuruFocus News • 9:58am
Mesoblast Ltd (MESO) Aligns with FDA for Biologics License Application for Revascor® | MESO stock news
GuruFocus News • 8:01pm
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
Marketwired • 8:00pm
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure | MESO Stock News
GuruFocus News • 7:45pm
Jun 12, 2025
Mesoblast (MEOBF) Advances FDA Discussions on Revascor and Ryoncil | MEOBF Stock News
GuruFocus News • 4:45am
Mesoblast Ltd (MESO) Advances FDA Discussions for Key Therapies | MESO stock news
GuruFocus News • 10:01pm
Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD
Marketwired • 9:00pm
Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD | MESO Stock News
GuruFocus News • 8:45pm
May 15, 2025
Mesoblast (MEOBF) Gains Orphan-Drug Exclusivity for Ryoncil | MEOBF Stock News
GuruFocus News • 5:01am
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil® | MESO Stock News
GuruFocus News • 10:15pm
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
Marketwired • 10:00pm
Apr 30, 2025
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025 | MESO Stock News
GuruFocus News • 8:15pm
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025
Marketwired • 8:00pm
Apr 29, 2025
Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
Marketwired • 7:00pm
Apr 17, 2025
Mesoblast Ltd (MESO) Expands Coverage for Ryoncil® to 104 Million US Lives | MESO stock news
GuruFocus News • 10:01pm
Mesoblast (MESO) Expands Ryoncil Coverage to 104 Million Insured Lives | MEOBF Stock News
GuruFocus News • 9:00pm
Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives
Marketwired • 9:00pm
Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives | MESO Stock News
GuruFocus News • 8:45pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news